Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

Brooks Nader opens up about GLP-1 weight loss drugs and says women from all backgrounds reached out to her after her reality ...

Influencer Nabela Noor shared a video exploring her personal style this holiday season following a 60-pound weight loss.

This new patent follows a series of recent milestones for TempraMed, including exclusive distribution agreements across Israel, Turkey, and major European regions with partners such as Guri A.A.O, ...

A notable finding is that audiences are split on whether they see more pharma ads in 2025 compared to 2024. Nearly half of ...

Ozempic can cause nausea after greasy meals by slowing digestion and increasing fullness. A diet expert explains why this ...

The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

Natural products industry companies share overviews on the latest science on their dietary supplement branded ingredients and ...

For adults with type 2 diabetes mellitus (T2DM), glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy is associ ...

Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as new therapies expand global market leadership.

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...